Interpretation of the preferred reporting items for living systematic reviews and meta-analyses (PRISMA-LSR)_Chinese Journal of Evidence-Based Medicine

Authors：

GAO Zhuo ¹ , TIAN Chen ^2,3,4 , ZHENG Qingyong ^3,5 , LI Yimeng ² , HAN Siyu ² , TIAN Jinhui ^3,5 ,  GE Long ^2,3,4

1. School of Nursing, Gansu University of Chinese Medicine, Lanzhou 730000, P. R. China;
2. Department of Health Policy and Management, School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China;
3. Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China;
4. Key Laboratory of Evidence Based Medicine of Gansu Province, Lanzhou 730000, P. R. China;
5. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;

Corresponding author：

GE Long, Email: gelong2009@163.com

Keywords：

Living systematic reviews; Reporting guideline; PRISMA-LSR; Interpretation

DOI：

10.7507/1672-2531.202412093

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

LSR represent an evolving methodology for systematic review that is continuously updated to incorporate new evidence in a timely manner, ensuring that healthcare professionals and policymaker shave access to the most last information to make optimal decisions. The global publication of LSR has been a rapid increase. But the quality of reporting remains to be enhanced. In 2024, the PRISMA-LSR working group, in conjunction with the characteristics of LSR to form the reporting standards for living systematic reviews, which plays a significant role in promoting the transparent, complete, and accurate reporting of LSR. It has been published in the BMJ journal. This article interpreted PRISMA-LSR with representative examples, aiming to provide a reference for the standardization of LSR by domestic scholars.

1.	Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 2009, 339: b2535.
2.	Veginadu P, Calache H, Gussy M, et al. An overview of methodological approaches in systematic reviews. J Evid Based Med, 2022, 15(1): 39-54.
3.	Gao Y, Yang K, Cai Y, et al. Updating systematic reviews can improve the precision of outcomes: a comparative study. J Clin Epidemiol, 2020, 125: 108-119.
4.	Elliott JH, Turner T, Clavisi O, et al. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med, 2014, 11(2): e1001603.
5.	许吉, 邓宏勇. 动态系统评价简介. 中国循证医学杂志, 2020, 20(2): 244-248.
6.	周川茹, 雷常彬, 王聪, 等. Cochrane快速系统评价的定义特征和方法学解读. 中国循证医学杂志, 2023, 23(2): 240-248.
7.	田晨, 刘佳宁, 田金徽, 等. 动态系统评价制作方法与流程. 中国全科医学, 2025, (1): 1-8.
8.	郑卿勇, 程露颖, 许建国, 等. 动态系统评价的研究现状与进展. 中国药物评价, 2021, 38(6): 471-478.
9.	Zheng Q, Xu J, Gao Y, et al. Past, present and future of living systematic review: a bibliometrics analysis. BMJ Glob Health, 2022, 7(10): e009378.
10.	Siemieniuk RA, Bartoszko JJ, Zeraatkar D, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ, 2020, 370: m2980.
11.	Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021, 372: n71.
12.	Akl EA, Khabsa J, Iannizzi C, et al. Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation. BMJ, 2024, 387: e079183.
13.	Khamis AM, Kahale LA, Pardo-Hernandez H, et al. Methods of conduct and reporting of living systematic reviews: a protocol for a living methodological survey. F1000Res, 2019, 8: 221.
14.	Kahale LA, Elkhoury R, El Mikati I, et al. Tailored PRISMA 2020 flow diagrams for living systematic reviews: a methodological survey and a proposal. F1000Res, 2021, 10: 192.
15.	高亚, 刘明, 杨珂璐, 等. 系统评价报告规范: PRISMA2020与PRISMA2009的对比分析与实例解读. 中国循证医学杂志, 2021, 21(5): 606-616.
16.	张迁, 王琪, 后亮瑛, 等. 动态指南制订方法及案例介绍. 中国循证医学杂志, 2021, 21(4): 491-496.
17.	田晨, 杨秋玉, 孙铭谣, 等. 快速动态循证指南制订方法. 协和医学杂志, 2024, 15(1): 183-191.
18.	田晨, 孙铭谣, 李颖, 等. 快速动态循证要览制订方法与流程. 中国循证医学杂志, 2023, 23(4): 450-456.
19.	Counotte MJ, Kim CR, Wang J, et al. Sexual transmission of Zika virus and other flaviviruses: A living systematic review. PLoS Med, 2018, 15(7): e1002611.
20.	Lawrenson JG, Shah R, Huntjens B, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev, 2023, 2(2): CD014758.
21.	Ebrahimzadeh S, Islam N, Dawit H, et al. Thoracic imaging tests for the diagnosis of COVID-19. Cochrane Database Syst Rev, 2022, 5(5): CD013639.
22.	Rethlefsen ML, Kirtley S, Waffenschmidt S, et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev, 2021, 10(1): 39.
23.	Simmonds M, Salanti G, McKenzie J, et al. Living systematic reviews: 3. Statistical methods for updating meta-analyses. J Clin Epidemiol, 2017, 91: 38-46.
24.	Uttley L, Quintana DS, Montgomery P, et al. The problems with systematic reviews: a living systematic review. J Clin Epidemiol, 2023, 156: 30-41.
25.	Akl EA, Meerpohl JJ, Elliott J, et al. Living systematic reviews: 4. Living guideline recommendations. J Clin Epidemiol, 2017, 91: 47-53.
26.	Kahale LA, Piechotta V, McKenzie JE, et al. Extension of the PRISMA 2020 statement for living systematic reviews (LSRs): protocol. F1000Res, 2022, 11: 109.
27.	Millard T, Synnot A, Elliott J, et al. Feasibility and acceptability of living systematic reviews: results from a mixed-methods evaluation. Syst Rev, 2019, 8(1): 325.
28.	Goldacre B, Morton CE, DeVito NJ. Why researchers should share their analytic code. BMJ, 2019, 367: l6365.
29.	Mello MM, Lieou V, Goodman SN. Clinical trial participants' views of the risks and benefits of data sharing. N Engl J Med, 2018, 378(23): 2202-2211.

1. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 2009, 339: b2535.
2. Veginadu P, Calache H, Gussy M, et al. An overview of methodological approaches in systematic reviews. J Evid Based Med, 2022, 15(1): 39-54.
3. Gao Y, Yang K, Cai Y, et al. Updating systematic reviews can improve the precision of outcomes: a comparative study. J Clin Epidemiol, 2020, 125: 108-119.
4. Elliott JH, Turner T, Clavisi O, et al. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med, 2014, 11(2): e1001603.
5. 许吉, 邓宏勇. 动态系统评价简介. 中国循证医学杂志, 2020, 20(2): 244-248.
6. 周川茹, 雷常彬, 王聪, 等. Cochrane快速系统评价的定义特征和方法学解读. 中国循证医学杂志, 2023, 23(2): 240-248.
7. 田晨, 刘佳宁, 田金徽, 等. 动态系统评价制作方法与流程. 中国全科医学, 2025, (1): 1-8.
8. 郑卿勇, 程露颖, 许建国, 等. 动态系统评价的研究现状与进展. 中国药物评价, 2021, 38(6): 471-478.
9. Zheng Q, Xu J, Gao Y, et al. Past, present and future of living systematic review: a bibliometrics analysis. BMJ Glob Health, 2022, 7(10): e009378.
10. Siemieniuk RA, Bartoszko JJ, Zeraatkar D, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ, 2020, 370: m2980.
11. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021, 372: n71.
12. Akl EA, Khabsa J, Iannizzi C, et al. Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation. BMJ, 2024, 387: e079183.
13. Khamis AM, Kahale LA, Pardo-Hernandez H, et al. Methods of conduct and reporting of living systematic reviews: a protocol for a living methodological survey. F1000Res, 2019, 8: 221.
14. Kahale LA, Elkhoury R, El Mikati I, et al. Tailored PRISMA 2020 flow diagrams for living systematic reviews: a methodological survey and a proposal. F1000Res, 2021, 10: 192.
15. 高亚, 刘明, 杨珂璐, 等. 系统评价报告规范: PRISMA2020与PRISMA2009的对比分析与实例解读. 中国循证医学杂志, 2021, 21(5): 606-616.
16. 张迁, 王琪, 后亮瑛, 等. 动态指南制订方法及案例介绍. 中国循证医学杂志, 2021, 21(4): 491-496.
17. 田晨, 杨秋玉, 孙铭谣, 等. 快速动态循证指南制订方法. 协和医学杂志, 2024, 15(1): 183-191.
18. 田晨, 孙铭谣, 李颖, 等. 快速动态循证要览制订方法与流程. 中国循证医学杂志, 2023, 23(4): 450-456.
19. Counotte MJ, Kim CR, Wang J, et al. Sexual transmission of Zika virus and other flaviviruses: A living systematic review. PLoS Med, 2018, 15(7): e1002611.
20. Lawrenson JG, Shah R, Huntjens B, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev, 2023, 2(2): CD014758.
21. Ebrahimzadeh S, Islam N, Dawit H, et al. Thoracic imaging tests for the diagnosis of COVID-19. Cochrane Database Syst Rev, 2022, 5(5): CD013639.
22. Rethlefsen ML, Kirtley S, Waffenschmidt S, et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev, 2021, 10(1): 39.
23. Simmonds M, Salanti G, McKenzie J, et al. Living systematic reviews: 3. Statistical methods for updating meta-analyses. J Clin Epidemiol, 2017, 91: 38-46.
24. Uttley L, Quintana DS, Montgomery P, et al. The problems with systematic reviews: a living systematic review. J Clin Epidemiol, 2023, 156: 30-41.
25. Akl EA, Meerpohl JJ, Elliott J, et al. Living systematic reviews: 4. Living guideline recommendations. J Clin Epidemiol, 2017, 91: 47-53.
26. Kahale LA, Piechotta V, McKenzie JE, et al. Extension of the PRISMA 2020 statement for living systematic reviews (LSRs): protocol. F1000Res, 2022, 11: 109.
27. Millard T, Synnot A, Elliott J, et al. Feasibility and acceptability of living systematic reviews: results from a mixed-methods evaluation. Syst Rev, 2019, 8(1): 325.
28. Goldacre B, Morton CE, DeVito NJ. Why researchers should share their analytic code. BMJ, 2019, 367: l6365.
29. Mello MM, Lieou V, Goodman SN. Clinical trial participants' views of the risks and benefits of data sharing. N Engl J Med, 2018, 378(23): 2202-2211.

Chinese Journal of Evidence-Based Medicine

Latest ArticlesInterpretation of the preferred reporting items for living systematic reviews and meta-analyses (PRISMA-LSR)

Abstract Full text Figures/Tables Video References Cited by

Format

Content